Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa

Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation

NCT02067182 ·Status: COMPLETED ·Phase: PHASE4

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

NCT02061748 ·Status: COMPLETED

Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF

NCT02256683 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

NCT02164864 ·Status: COMPLETED ·Phase: PHASE3

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 ·Status: UNKNOWN

Effect of Inhibitors of the Proton Pump on Intestinal Transporters

NCT02524210 ·Status: COMPLETED ·Phase: PHASE1

Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon

NCT02591225 ·Status: UNKNOWN ·Phase: PHASE4

Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

NCT02754154 ·Status: COMPLETED

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

NCT05038228 ·Status: ACTIVE_NOT_RECRUITING

Sequential Expansion of Comparative Effectiveness of Anticoagulants

NCT02081807 ·Status: COMPLETED

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

NCT03742336 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

NCT02043808 ·Status: COMPLETED

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

NCT00781391 ·Status: COMPLETED ·Phase: PHASE3

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

NCT02072434 ·Status: COMPLETED ·Phase: PHASE3

Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation

NCT03280368 ·Status: COMPLETED

Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention

NCT00818753 ·Status: COMPLETED ·Phase: PHASE2

Monitor System for the Safety of Dabigatran Treatment

NCT02414035 ·Status: COMPLETED

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

NCT01153698 ·Status: TERMINATED

Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

NCT04878497 ·Status: UNKNOWN

Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation

NCT03666962 ·Status: UNKNOWN

Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation

NCT03061006 ·Status: COMPLETED ·Phase: PHASE4

AntiCoagulation Tracking InterVention and Evaluation

NCT04059965 ·Status: WITHDRAWN ·Phase: NA

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

NCT01675076 ·Status: COMPLETED ·Phase: PHASE3

Pleotropic Effect of New Oral Anticoagulants

NCT02544932 ·Status: UNKNOWN ·Phase: PHASE3